Anapol Weiss is an award-winning personal injury and mass torts litigation firm that has been representing victims of negligence for over 40 years. The firm has a proven track record of securing millions of dollars in compensation for individuals injured by drugs and medical devices, medical malpractice, auto accidents, toxic materials, product defects, and other intricate personal injury cases. The attorneys at Anapol Weiss have played pivotal roles in various national mass tort litigations involving defective medical devices and dangerous pharmaceutical products. They are currently involved in investigating lawsuits concerning Juul e-cigarettes, flu vaccines, Zantac, and more. Moreover, the firm has been at the forefront of cutting-edge class action litigations and has served in significant positions in high-profile cases such as the NFL concussion litigation and the Kids for Cash Judicial Scandal Class Action Litigation. Anapol Weiss is nationally recognized for its successes in complex car, bus, and truck cases, automotive defect claims, medical malpractice lawsuits, mesothelioma and asbestos claims, and more. The firm's attorneys have also successfully represented clients before the U.S. Court of Appeals in Washington, D.C. as part of the National Vaccine Injury Compensation Program. With a strong emphasis on teamwork, the firm provides clients with over 350 years of combined legal experience dedicated to their lawsuit. Anapol Weiss has received accolades such as the highest Tier 1 ranking in Best Law Firms® and has seen three of its partners named Philadelphia Lawyer of the Year by Best Lawyers®. Additionally, numerous attorneys from the firm have been included in Pennsylvania Super Lawyers® and the National Law Journal’s Top 40 Under 40 list. Founded in 1977, Anapol Weiss operates in the Health Care industry and is headquartered in the United States. Despite not having any publicly disclosed recent investments, the firm's extensive experience, successful track record, and industry recognition position it as a compelling entity within the legal profession. For more information and consultation, please visit www.anapolweiss.com.
There is no investment information
No recent news or press coverage available for Anapol Weiss.